Skip to main content

Advertisement

Table 3 Clinical and Biochemical Characteristics of Stages 0–2 and Stages 3–4 NAFLD

From: Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)

  Stages 0–2 NAFLD Stages 3–4 NAFLD P value
Age (years) 51.5 ± 13.4 52.8 ± 15.1 0.7564
BMI (m/kg2) 28.1 ± 4.9 30.2 ± 6.7 0.2133
VFA (cm2) 132.1 ± 63.7 135.7 ± 33.4 0.8716
SFA (cm2) 216.9 ± 95.3 256.8 ± 108.2 0.0626
AST (U/ml) 54.6 ± 41.0 58.1 ± 26.9 0.7526
ALT (U/ml) 80.3 ± 49.3 82.4 ± 59.5 0.8903
FBS (mg/dl) 122.9 ± 39.9 112.3 ± 17.8 0.3598
IRI (ul/ml) 13.0 ± 9.06 18.3 ± 9.10 0.0762
HOMA-IR 3.56 ± 2.59 5.16 ± 2.43 0.0677
HDL cholesterol (mg/l) 50.1 ± 12.5 47.8 ± 10.2 0.5277
LDL cholesterol (mg/l) 130.6 ± 33.3 129.8 ± 41.0 0.9430
Albumin (mg/l) 4.55 ± 0.27 4.23 ± 0.66 0.0170
Platelet count (ng/ml) 25.8 ± 6.6 20.0 ± 8.7 0.0134
Hyaluronic acid (ng/dl) 32.7 ± 27.8 72.4 ± 68.1 0.0090
Type IV collagen 7s (ng/dl) 4.65 ± 0.93 5.94 ± 1.53 0.0018
  1. Data are expressed as means ± SD. VFA: visceral fat area, SFA: subcutaneous fat area, AST: aspartate aminotransferase, ALT: alanine aminotransferase, FBS: fasting blood sugar, IRI: immunoreactive insulin, HOMA-IR: homeostasis model assessment of insulin resistance.